The US FDA is considering elevating patient engagement to a more visible position by establishing a central office for the programs.
The agency said in a Federal Register notice expected to be published March 14 that it is seeking comments on its idea to create an Office of Patient...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?